Taiwan FDA registration 1b1fdd3a4de2273ba5922ab9d5cdf439
Longteng cannabis in vitro reagent group
TW: 龍騰大麻體外試劑組
Taiwan·Risk Class 2·The first factory of Longteng Biotechnology Co., Ltd·Registered Nov 04, 2008 – Nov 04, 2018CancelledRegistration details
- Analysis ID
- 1b1fdd3a4de2273ba5922ab9d5cdf439
- Customs Code
- DHY00500261401
Company information
- Manufacturer Country
- Taiwan, Province of China
- Authorized Representative
- The first factory of Longteng Biotechnology Co., Ltd
Product details
- Intended Use
- Qualitative detection of cannabis and its metabolites in human urine.
- Product Type (Level 1)
- A Clinical chemistry and clinical toxicology
- Product Type (Level 2)
- A.3870 Cannabis Trial System
- Import Information
- Domestic
Dates and status
- Registration Date
- Nov 04, 2008
- Expiry Date
- Nov 04, 2018
- Cancellation Date
- Jun 27, 2022
Cancellation information
- Status
- Logged out
- Reason
- 許可證已逾有效期
About this record
Access comprehensive regulatory information for Longteng cannabis in vitro reagent group in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number 1b1fdd3a4de2273ba5922ab9d5cdf439 and manufactured by The first factory of Longteng Biotechnology Co., Ltd. The authorized representative in Taiwan is The first factory of Longteng Biotechnology Co., Ltd.
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Free DatabasePowered by Pure Global AI89,000+ Devices